Neuroblastoma trials in Hong Kong
1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleQuadruple Immunotherapy for Neuroblastoma
- Where
- Hong Kong
- Age
- Up to 18 years
- People
- 29
- Run by
- Hong Kong Children's Hospital
See details and how to joinNCT05754684